Addex Therapeutics (ADXN) Research & Development (2022 - 2025)
Historic Research & Development for Addex Therapeutics (ADXN) over the last 4 years, with Q3 2025 value amounting to -$285419.5.
- Addex Therapeutics' Research & Development fell 2091.4% to -$285419.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 2982.84%. This contributed to the annual value of $971089.9 for FY2024, which is 2650.58% down from last year.
- Latest data reveals that Addex Therapeutics reported Research & Development of -$285419.5 as of Q3 2025, which was down 2091.4% from -$283194.7 recorded in Q2 2025.
- Over the past 5 years, Addex Therapeutics' Research & Development peaked at $21.3 million during Q4 2022, and registered a low of -$6.0 million during Q2 2022.
- Moreover, its 4-year median value for Research & Development was -$283194.7 (2025), whereas its average is $665837.6.
- Within the past 5 years, the most significant YoY rise in Addex Therapeutics' Research & Development was 9456.55% (2023), while the steepest drop was 8822.8% (2023).
- Addex Therapeutics' Research & Development (Quarter) stood at $21.3 million in 2022, then tumbled by 88.23% to $2.5 million in 2023, then dropped by 25.19% to $1.9 million in 2024, then plummeted by 115.22% to -$285419.5 in 2025.
- Its Research & Development was -$285419.5 in Q3 2025, compared to -$283194.7 in Q2 2025 and -$173584.5 in Q1 2025.